Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health-related quality of life in cirrhotic patients

Liver International

Volumn 31, Issue 10, 2011, Pages 1505-1510

  Moscucci, Federica ^a   Nardelli, Silvia ^a   Pentassuglio, Ilaria ^a   Pasquale, Chiara ^a   Ridola, Lorenzo ^a   Merli, Manuela ^a   Riggio, Oliviero ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Ascites; Health related quality of life; Liver cirrhosis; Minimal and overt hepatic encephalopathy; Psychometric Hepatic Encephalopathy Score; Short Form 36

Indexed keywords

ADULT; AGE; AGED; ARTICLE; ASCITES; COHORT ANALYSIS; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; DISEASE SEVERITY; EDUCATIONAL STATUS; EMOTION; FEMALE; HEPATIC ENCEPHALOPATHY; HOSPITAL PATIENT; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; PAIN; PHYSICAL ACTIVITY; PSYCHOMETRIC HEPATIC ENCEPHALOPATHY SCORE; PSYCHOMETRY; QUALITY OF LIFE; SCORING SYSTEM; SHORT FORM 36; SOCIAL INTERACTION;

AGED; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS;

EID: 80053935046     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02598.x     Document Type: Article

References (27)

1. Everhart J. Digestive diseases in the United States: epidemiology and impact. NIH Publication no. 94-1447, 1994.
2. Marchesini G, Bianchi G, Amodio P, et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 2001; 120: 170-8.
3. Bajaj JS, Schubert CM, Heuman DM, et al. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology 2010; 138: 2332-40.
4. Riggio O, Ridola L, Pasquale C, et al. Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy. Clin Gastroenterol Hepatol 2011 Feb; 9:181-3. Epub 2010 Oct 15.
5. McNeil BJ, Weichselbaum R, Pauker SG, et al. Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer. N Engl J Med 1981; 305: 982-7.
6. Bao ZJ, Qiu DK, Ma X, et al. Assessment of health-related quality of life in Chinese patients with minimal hepatic encephalopathy. World J Gastroenterol 2007; 13: 3003-8.
7. Groeneweg M, Quero JC, De Bruijn I, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998; 28: 45-9.
8. Prasad S, Dhiman RK, Duseja A, et al. Lactulose improves cognitive functions and Health-Related Quality of Life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007; 45: 549-59.
9. Sidhu SS, Bholeshwar OG, Mishra P, et al. Rifaximin improves psychometric perdormance and Health-Related Quality of Life in patients with minimal hepatic encephalopathy (The RIME Trial). Am J Gastroenterol 2011; 106: 307-16.
10. Arguedas MR, Lawrence TG, McGuire BM, et al. Influence of hepatic encephalopathy on Health Related Quality of Life in cirrhosis. Dig Dis Sci 2003; 48: 1622-26.
11. Conn HO, Leevy CM, Vlahcevic ZR, et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977; 72: 573-83.
12. Ortiz M, Córdoba J, Doval E, et al. Development of a clinical hepatic encephalopathy staging scale. Aliment Pharmacol Ther 2007; 26: 859-67.
13. Guo QH, Cao XY, Zhou Y, et al. Application study of quick cognitive screening test in identifying mild cognitive impairment. Neurosci Bull 2010; 26: 47-54.
14. Amodio P, Campagna F, Olianas S, et al. Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study. J Hepatol 2008; 49: 346-53.
15. Riggio O, Ridola L, Pasquale C, et al., A simplified psychometric evaluation for the diagnosis of minimal hepatic encephalopathy. Clin Gastroenterol Hepatol 2011; 9: 613-6. e1.
16. Weissenborn K, Ennen JC, Schomerus H, et al. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34: 768-73.
17. Schomerus H, Hamster W. Neuropsychological aspects of portal-systemic encephalopathy. Metab Brain Dis 1998; 13: 361-77.
18. Apolone G, Mosconi P. The Italian SF-36 Heath Survey: translation, validation and norming. J Clin Epidemiol 1998; 51: 1025-36.
19. Younossi ZM, Boparai N, Price LP, et al. Heath related quality of live in chronic liver disease:the impact of type and severity of disease. Am J Gastroenterol 2001; 96: 2199-205.
20. Córdoba J, Flavià M, Jacas C, et al. Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatology 2003; 39: 231-8.
21. Häuser W, Holtmann G, Grandt D, et al. Determinants of Health-Related Quality of Life in patients with chronic liver disease. Clin Gastroenterol Hepatol 2004; 2: 157-163.
22. Saab S, Ibrahim AB, Shpaner A, et al. MELD fails to measure Quality of Life in liver transplant candidates. Liver Transpl 2005; 11: 218-23.
23. Qadr AM, Ogunwale BO, Mullen KD, et al. Can we ignore minimal hepatic encephalopathy any longer?. Hepatology Editorial, March 2007; 45: 547-8.
24. Bajaj J S, Heuman DM, Wade JB, et al. Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology, 2011; 140: 478-87. e1.
25. Bajaj JS, Saeian K, Christensen KM, et al. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol 2008; 103: 1707-15.
26. Tan HH, Lee GH, Thia KT, et al. Minimal hepatic encephalopathy runs a fluctuating course: results form a three-years prospective cohort follow-up study. Singapore Med J. 2009 Mar; 50: 255-60.
27. Les I, Doval E, Flavià M, et al. Quality of life in cirrhosis is related to potentially treatable factors. Eur J Gastroenterol Hepatol 2010; 22: 221-7.